Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier

被引:115
|
作者
Gaillard, PJ [1 ]
van der Sandt, ICJ [1 ]
Voorwinden, LH [1 ]
Vu, D [1 ]
Nielsen, JL [1 ]
de Boer, AG [1 ]
Breimer, DD [1 ]
机构
[1] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Dept Pharmacol, NL-2300 RA Leiden, Netherlands
关键词
blood-brain barrier; brain capillary endothelial cells; astrocytes; P-glycoprotein; vinblastine exclusion assay; multidrug resistance;
D O I
10.1023/A:1026406528530
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose: To investigate the influence of astrocytes on P-glycoprotein (Pgp) expression and intracellular accumulation of Pgp substrates, separate from their net transcelluIar transport across the blood-brain barrier (BBB). Methods. An in vitro BBB model was used, comprising of brain capillary endothelial cells (BCEC) monolayers or BCEC co-cultured with astrocytes. Results. BCEC+astrocyte co-cultures seemed to express a higher level of Pgp compared to BCEC monolayers. Inhibition of Pgp results in an increased intracellular accumulation of Pgp substrates in both BCEC monolayers and BCEC+astrocyte co-cultures, and increased the sensitivity for vinblastine mediated disruption of the in vitro BBB (called the vinblastine exclusion assay). BCEC monolayers were more sensitive to vinblastine mediated disruption compared to BCEC+astrocyte co-cultures. In the latter, but not in BCEC monolayers, an inhibitable polar transport of Pgp substrates was only found from the brain to the blood side of the filter. Conclusions, Astrocytes increase the functional expression of Pgp in our in vitro BBB model. These results also illustrate that an important role for Pgp on the BBB is to protect the barrier against intracellular accumulation of cytotoxic BBB disrupting compounds.
引用
收藏
页码:1198 / 1205
页数:8
相关论文
共 50 条
  • [1] Astrocytes Increase the Functional Expression of P-Glycoprotein in an In Vitro Model of The Blood-Brain Barrier
    Pieter Jaap Gaillard
    Inez Cornelia Johanna van der Sandt
    Levina Helena Voorwinden
    Dung Vu
    Jette Lyngholm Nielsen
    Albertus Gerrit de Boer
    Douwe Durk Breimer
    Pharmaceutical Research, 2000, 17 : 1198 - 1205
  • [2] Involvement of P-glycoprotein in an in vitro blood-brain barrier model
    Joly, B
    Lecureur, V
    Puozzo, C
    Guillouzo, A
    Fardel, O
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (05) : 1029 - 1033
  • [3] P-glycoprotein activity in an in vitro blood-brain barrier model
    Joly, B
    Fardel, O
    Lecureur, V
    Chesne, C
    Puozzo, C
    Guillouzo, A
    BIOLOGY AND PHYSIOLOGY OF THE BLOOD-BRAIN BARRIER: TRANSPORT, CELLULAR INTERACTIONS, AND BRAIN PATHOLOGIES, 1996, 46 : 191 - 196
  • [4] The functional role of P-glycoprotein in the blood-brain barrier
    vanAsperen, J
    Mayer, U
    vanTellingen, O
    Beijnen, JH
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (08) : 881 - 884
  • [5] The strongest expression of P-glycoprotein is in the blood-brain barrier
    Beaulieu, E
    Demeule, M
    AverillBates, DA
    Beliveau, R
    BIOLOGY AND PHYSIOLOGY OF THE BLOOD-BRAIN BARRIER: TRANSPORT, CELLULAR INTERACTIONS, AND BRAIN PATHOLOGIES, 1996, 46 : 171 - 174
  • [6] Activated T cells modulate P-glycoprotein expression in an in vitro model of the blood-brain barrier
    Tan, KH
    Purcell, WM
    Heales, SJR
    McLeod, JD
    Hurst, RD
    JOURNAL OF PHYSIOLOGY-LONDON, 2002, 539 : 89P - 89P
  • [7] Blood-brain barrier function of P-glycoprotein
    Tsuji, A
    Tamai, I
    ADVANCED DRUG DELIVERY REVIEWS, 1997, 25 (2-3) : 287 - 298
  • [8] P-glycoprotein, a gatekeeper in the blood-brain barrier
    Schinkel, AH
    ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (2-3) : 179 - 194
  • [9] P-Glycoprotein, a gatekeeper in the blood-brain barrier
    Division of Experimental Therapy, Netherlands Cancer Inst., P., 1066 CX Amsterdam, Netherlands
    Adv. Drug Deliv. Rev., 2-3 (179-194):
  • [10] Influence of P-glycoprotein on brucine transport at the in vitro blood-brain barrier
    Xu, Dan-Hua
    Yan, Miao
    Li, Huan-De
    Fang, Ping-Fei
    Liu, Yan-Wen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 690 (1-3) : 68 - 76